Search

everythinglearnresearchcommunity

for

Search:↓

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Introducing the rat OTC gene partially corrected OTC deficiency in mice.

Nickel oxide nanoparticles made with plant extract can kill bacteria and fungi and break down dyes.

Less AgNOR protein production is linked to hair loss.

New cancer treatments aim to reduce side effects and improve effectiveness.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Basonuclin may help control ribosomal RNA gene activity in skin cells.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Nanotechnology can effectively deliver antimicrobial peptides for treating infections.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

Non-coding RNAs play key roles in the hair growth cycle of Angora rabbits.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Hair follicles and urine cell pellets are promising for transcriptome studies.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

Ornithine decarboxylase is crucial for hair growth and follicle development.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

A new treatment using gold nanoclusters can safely reduce unwanted hair growth.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Integrating biological networks improves drug repurposing and ADR prediction.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

The DNMT3B -579G>T polymorphism may increase the risk of colorectal cancer.